Are syngeneic donors a viable donor option in allogeneic haematopoietic cell transplantation for MDS? A brief report on behalf of the Chronic Malignancies Working Party of the EBMT and review of current literature
8 University Hospital Düsseldorf, Department of Hematology, Oncology and clinical Immunology, Heinrich Heine University, Medical Faculty, Düsseldorf, Germany.
9 Dél-pesti Centrumkórház, Budapest, Hungary.
10 Imperial College, London, United Kingdom.
11 BMT Center "Louis Turcanu" Emergency Hospital for Children, Timisoara, Romania.
12 CHU ESTAING, Clermont-Ferrand, France.
13 Klinikum Oldenburg, Oldenburg, Germany.
14 Biomedical Data Sciences, Leiden University Medical Center, Leiden, the Netherlands.
15 Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland.
16 ASST GRANDE OSPEDALE METROPOLITANO NIGUARDA, Milano, Italy.
17 Hospital Morales Meseguer, Murcia, Spain.
18 Kings College Hospital, London, United Kingdom.
19 Klinikum Grosshadern, Munich, Germany.
20 Riga East University hospital, Riga, Latvia.
21 University Hospital Innsbruck, Innsbruck, Austria.
22 Central Clinical Hospital, The Medical University of Warsaw, Warsaw, Poland.
23 University College London Hospitals NHS Trust, London, United Kingdom.
24 Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy.
25 Translational Hematology and Oncology Research Department, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA.
26 CHRU Lille, Lille, France.
27 Fondazione IRCCS - Ca' Granda - Ospedale Maggiore Policlinico IRCCS, Milan, Italy.